Drugs / Recombinant Vesicular Stomatitis Virus-expressing Interferon-beta
Recombinant Vesicular Stomatitis Virus-expressing Interferon-beta
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01628640 | Aug 2012 → Apr 2019 | hepatocellular carcinoma | Mayo Clinic | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Recombinant Vesicular Stomatitis Virus-expressing Interferon-beta | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01628640 ↗ |
| Route | Other | “Given intratumorally” NCT01628640 ↗ |